Camille L. Bedrosian - Insider Trading & Ownership

Entity
Individual
Location
C/O Ultragenyx Pharmaceutical Inc., 60 Leveroni Court, Novato, CA
Summary
The estimated net worth of Camille L. Bedrosian is at least $2.31M dollars as of December 3, 2024. Camille L. Bedrosian is the EVP and Chief Medical Officer of Ultragenyx Pharmaceutical Inc. and owns shares of Ultragenyx Pharmaceutical Inc. (RARE) stock worth about $981K. Camille L. Bedrosian is the Chief Medical Officer of Amylyx Pharmaceuticals, Inc. and owns shares of Amylyx Pharmaceuticals, Inc. (AMLX) stock worth about $766K. Camille L. Bedrosian is the Director of Crinetics Pharmaceuticals, Inc. and owns shares of Crinetics Pharmaceuticals, Inc. (CRNX) stock worth about $446K. Camille L. Bedrosian is the Director of RHYTHM PHARMACEUTICALS, INC. and owns shares of RHYTHM PHARMACEUTICALS, INC. (RYTM) stock worth about $117K.
All Insider Reports
All Insider Reports

Ownership of Camille L. Bedrosian

Insider Transactions Reported by Camille L. Bedrosian:

* An asterisk sign (*) next to the price indicates that the price is likely invalid.